Posted in | Medical Robotics

Mercy Medical Center Achieves 63% Annual Savings Through Health Robotics' i.v.STATION

Health Robotics recently announced that Mercy Medical Center in Cedar Rapids released to Health Robotics' User Group an ROI study revealing 63% annual savings [or $313,918] as a result of insourcing just 4 active pharmaceutical ingredients (APIs) for sterile compounding patient doses on the i.v.STATION Robot [at an insourced cost of $184,988), compared to Mercy Medical Center's prior equivalent annual expense with PharMedium Services of $498,886 for the equivalent doses of these 4 APIs.

i.v.STATION utilized standard BD syringes and Hospira IV Bags, with drug vials for Zosyn [Pfizer], Vancomycin [Pfizer, APP, and Hospira], Cefazolin [Sandoz and APP], and Heparin [APP, Sagent, and Hospira].

Amy Cobb, Mercy Medical Center's Director of Pharmacy Operations stated: "Our single i.v.STATION Robot prepared Zosyn powder reconstitutions and dilutions at an insourced cost of $122,888, compared to the equivalent annual PharMedium expense of $241,835, saving Mercy a total of $118,947 on a single API for 50 and 100ml Bags. At the same time, i.v.STATION also prepared Heparin dilutions at an internal annual cost of $22,440 for 5ml syringes compared to the equivalent annual PharMedium outlay of $113,220, saving Mercy a total of $90,780 on a single API."

Gaspar DeViedma, Health Robotics' Executive Vice President stated: "This represents a record 5-month payback for i.v.STATION, while 50+ outsourcing compounding centers [including 4 PharMedium locations in Memphis, Edison, Sugarland, and Cleveland] have been issued Forms 483 by the FDA for quality events during 2013 inspections. If this ROI and the tragic NECC meningitis events from 2012 do not make the case for Sterile Compounding Insourcing at hospital pharmacies with the i.v.STATION Robot, then I really wonder what ever will."

Ms. Cobb continued: "As far as Vancomycin, the same i.v.STATION Robot also prepared powder reconstitutions and dilutions on D5W, SWFI, and NS at an insourced cost of $22,500 compared to the equivalent annual PharMedium outlay of $106,165, saving Mercy a total of $83,665 on a single API for BD 20ml syringes and 100, 250 and 500ml Bags. Finally, the study showed that for Cefazolin, i.v.STATION additionally prepared powder reconstitutions and dilutions on D5W and NS at an internal cost of $17,160 compared to the equivalent annual PharMedium expense of $37,686, saving Mercy Medical Center a total of $20,526 on a single API for BD 20ml syringes and 50 and 100ml Bags."

Source: http://www.health-robotics.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Health Robotics. (2019, February 19). Mercy Medical Center Achieves 63% Annual Savings Through Health Robotics' i.v.STATION. AZoRobotics. Retrieved on July 09, 2020 from https://www.azorobotics.com/News.aspx?newsID=4605.

  • MLA

    Health Robotics. "Mercy Medical Center Achieves 63% Annual Savings Through Health Robotics' i.v.STATION". AZoRobotics. 09 July 2020. <https://www.azorobotics.com/News.aspx?newsID=4605>.

  • Chicago

    Health Robotics. "Mercy Medical Center Achieves 63% Annual Savings Through Health Robotics' i.v.STATION". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=4605. (accessed July 09, 2020).

  • Harvard

    Health Robotics. 2019. Mercy Medical Center Achieves 63% Annual Savings Through Health Robotics' i.v.STATION. AZoRobotics, viewed 09 July 2020, https://www.azorobotics.com/News.aspx?newsID=4605.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit